Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2008 2
2009 1
2010 1
2013 3
2014 3
2015 2
2017 5
2018 2
2019 6
2020 12
2021 10
2022 3
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Glycans in drug discovery.
Valverde P, Ardá A, Reichardt NC, Jiménez-Barbero J, Gimeno A. Valverde P, et al. Among authors: gimeno a. Medchemcomm. 2019 Jul 26;10(10):1678-1691. doi: 10.1039/c9md00292h. eCollection 2019 Oct 1. Medchemcomm. 2019. PMID: 31814952 Free PMC article. Review.
Targeting Galectins With Glycomimetics.
Bertuzzi S, Quintana JI, Ardá A, Gimeno A, Jiménez-Barbero J. Bertuzzi S, et al. Among authors: gimeno a. Front Chem. 2020 Aug 7;8:593. doi: 10.3389/fchem.2020.00593. eCollection 2020. Front Chem. 2020. PMID: 32850631 Free PMC article. Review.
Early neonatal death: A challenge worldwide.
Lehtonen L, Gimeno A, Parra-Llorca A, Vento M. Lehtonen L, et al. Among authors: gimeno a. Semin Fetal Neonatal Med. 2017 Jun;22(3):153-160. doi: 10.1016/j.siny.2017.02.006. Epub 2017 Feb 24. Semin Fetal Neonatal Med. 2017. PMID: 28238633 Review.
Glycans in Infectious Diseases. A Molecular Recognition Perspective.
Unione L, Gimeno A, Valverde P, Calloni I, Coelho H, Mirabella S, Poveda A, Arda A, Jimenez-Barbero J. Unione L, et al. Among authors: gimeno a. Curr Med Chem. 2017 Nov 24;24(36):4057-4080. doi: 10.2174/0929867324666170217093702. Curr Med Chem. 2017. PMID: 28215157 Review.
55 results